cbdMD, Inc.

cbdMD, Inc. is a U.S.-based consumer products company that develops and sells hemp-derived wellness products under brands including cbdMD, Paw CBD, ATRx Labs, and Herbal Oasis. Its portfolio spans CBD tinctures, gummies, topicals, capsules, sleep and focus aids, functional mushroom products, and THC-infused beverages, sold through e-commerce, wholesale, and selected retail channels.

−9,4 %

62,4 %

−10,6 %

−1,5 %

2.05

1.13

— cbdMD, Inc.
	%
CBD wellness products	55% Broad-spectrum and full-spectrum hemp-derived CBD products for human use.
Pet wellness products	10% CBD-based products sold under Paw CBD for pet health and wellness.
Functional mushroom and nootropic products	10% ATRx Labs products focused on mushroom-based and cognitive wellness formulations.
THC beverages	15% Herbal Oasis hemp-derived THC-infused ready-to-drink beverage products.
Wholesale and retail channel sales	10% Sales through retail accounts, distributors, and other third-party channels.

cbdMD sells primarily to consumers buying directly online, as well as wholesale and retail partners that stock its...

Direct-to-consumer wellness shoppersprimary
Buy CBD and wellness products online or by phone for convenience and brand selection.
Wholesale retail accountsprimary
Retailers and specialty chains buy branded SKUs to sell through physical stores.
Distributorssecondary
Regional and category distributors buy products to expand market reach and placement.
Pet ownerssecondary
Buy Paw CBD products for pet wellness and companion-animal use cases.
International consumers and partnersemerging
Buy through local wholesalers, legal partners, and e-commerce channels outside the U.S.

cbdMD is headquartered in Charlotte, North Carolina and operates primarily in the United States...

•Headquartered and operated from Charlotte, North Carolina
•Primary sales and distribution market is the United States
•UK e-commerce sales support international consumer reach
•Central and South America are targeted through local partners
•State-by-state U.S. distribution matters for hemp and THC products
•Local legal and regulatory partners are used in foreign markets

cbdMD is focused on expanding its revenue channels across direct-to-consumer, wholesale, and retail distribution while...

Broaden distribution for Oasis and other brandsshort-term

More retail and distributor placements increase product availability and brand scale.

Improve direct-to-consumer marketing efficiencyshort-term

Online sales depend on cost-effective customer acquisition and repeat purchasing.

Build a multi-brand wellness platformmedium-term

Multiple brands can broaden the addressable market and reduce reliance on one product line.

Expand internationally through compliant channelsmedium-term

Foreign markets can add growth, but require local regulatory navigation.

The business is exposed to regulatory scrutiny around hemp-derived cannabinoids, especially advertising and product...

high

Regulatory enforcement on CBD and THC claims

The company markets hemp-derived wellness products that can attract FTC/FDA scrutiny.

Scope: Advertising, labeling, and product claims
Materiality: high

high

Customer acquisition efficiency

Online sales rely on paid marketing and may become more expensive over time.

Scope: E-commerce channel
Materiality: high

high

Going concern / continued losses

A history of operating losses can constrain investment and strategic flexibility.

Scope: Corporate level
Materiality: high

medium

State-level packaging and labeling changes

Different jurisdictions may require reworks and reformulation of packaging materials.

Scope: Wholesale and beverage distribution
Materiality: high

medium

International regulatory complexity

Foreign sales require local legal counsel and market-specific approvals.

Scope: UK, Central America, South America
Materiality: medium

Revenue recognition and returns reserve

Affects reported net sales and comparability across periods

Inventory valuation

Can materially affect cost of sales and gross margin

Advertising and marketing expense

Creates period-to-period volatility in operating expenses

Intangible assets and amortization

Can affect operating income and equity values

Lease accounting

Affects operating expenses and balance sheet obligations

cbdMD, Inc.

Regulatory enforcement on CBD and THC claims

Customer acquisition efficiency

Going concern / continued losses

State-level packaging and labeling changes

International regulatory complexity

InMed Pharmaceuticals Inc.

InspireMD, Inc.

DYADIC INTERNATIONAL INC

LifeMD, Inc.

CV Sciences, Inc.

Modular Medical, Inc.